Human antibody responses to A and C capsular polysaccharides, IgA1 protease and transferrin-binding protein complex stimulated by infection with Neisseria meningitidis of subgroup IV-1 or ET-37 complex

Vaccine

Volumn 17, Issue 7-8, 1999, Pages 731-744

  Brieske, Norbert ^a   Schenker, Martin ^a   Schnibbe, Thomas ^a   Quentin Millet, Marie José ^b   Achtman, Mark ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^b 1541 Ave Marcel Merieux 69280 ^*  (France)

Author keywords

Immunogenicity; Invasive disease; Meningococci; Nasopharyngeal carriage; Vaccine development

Indexed keywords

BACTERIAL ANTIGEN; IMMUNOGLOBULIN A1; PROTEINASE;

ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGENICITY; ARTICLE; DISEASE CARRIER; GAMBIA; GENETIC ANALYSIS; HUMAN; IMMUNOGENICITY; MALI; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STRAIN DIFFERENCE;

AMINO ACID SEQUENCE; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; CARRIER PROTEINS; EPITOPES; GAMBIA; HUMANS; IMMUNOGLOBULIN G; IRON-BINDING PROTEINS; MENINGITIS, MENINGOCOCCAL; MOLECULAR SEQUENCE DATA; NASOPHARYNX; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; SERINE ENDOPEPTIDASES; TRANSFERRIN-BINDING PROTEINS;

EID: 0033605221     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(98)00257-6     Document Type: Article

References (38)

1. Achtman M, Global epidemiology of meningococcal disease. In: Cartwright K, editor. Meningococcal disease. Chichester: John Wiley and Sons, 1995:159-175.
2. Wang J-F, Caugant D.A, Li Xet al. Clonal and antigenic analysis of serogroup A Neisseria meningitidis with particular reference to epidemiological features of epidemic meningitis in China. Infect Immun. 60:1992;5267-5282.
3. Binkin N, Band J Epidemic of meningococcal meningitis in Bamako, Mali: Epidemiological features and analysis of vaccine efficacy. Lancet. 2:1982;315-318.
4. WahdanM.H, Rizk F, El-Akkad A.Met al. A controlled field trial of a serogroup A meningococcal polysaccharide vaccine. Bull World Health Organ. 48:1973;667-673.
5. Erwa H.H, Haseeb M.A, Idris A.A, Lapeyssonnie L, Sanborn W.R, Sippel J.E A serogroup A meningococcal polysaccharide vaccine Studies in the Sudan to combat cerebrospinal meningitis caused by Neisseria meningitidis group A. Bull World Health Organ. 49:1973;301-305.
6. Bosmans E, Vimont-Vicary P, André F.E, Crooy P.J, Roelants P, Vandepitte J Protective efficacy of a bivalent (A+C) meningococcal vaccine during a cerebrospinal meningitis epidemic in Rwanda. Ann Soc Belg Med Trop. 60:1980;297-306.
7. Greenwood B.M, Smith A.W, Hassan-King Met al. The efficacy of meningococcal polysaccharide vaccine in preventing group A meningococcal disease in The Gambia, West Africa. Trans R Soc Trop Med Hyg. 80:1986;1006-1007.
8. Leach A, Twumasi P.A, Kumah Set al. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. J Infect Dis. 175:1997;200-204.
9. Lieberman J.M, Chiu S.S, Wong V.Ket al. Safety and immunogenicity of a serogroups A/C Neisseria meningitidis oligosaccharide-protein conjugate vaccine in young children. JAMA. 275:1996;1499-1503.
10. Rosenqvist E, Høiby E.A, Wedege Eet al. Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine. Infect Immun. 63:1995;4642-4652.
11. Van der Voort E.M.R, Kuipers B, Brugghe H.Fet al. Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines. FEMS Immunol Med Microbiol. 17:1997;139-148.
12. Lissolo L, Maitre-Wilmotte G, Dumas P, Mignon M, Danve B, Quentin-Millet M-J Evaluation of transferrin-binding protein 2 within the transferrin-binding protein complex as a potential antigen for future meningococcal vaccines. Infect Immun. 63:1995;884-890.
13. Rokbi B, Mignon M, Maitre-Wilmotte Get al. Evaluation of recombinant transferrin-binding protein B variants from Neisseria meningitidis for their ability to induce cross-reactive and bactericidal antibodies against a genetically diverse collection of serogroup B strains. Infect Immun. 65:1997;55-63.
14. Brooks G.F, Lammel C.J, Blake M.S, Kusecek B, Achtman M Antibodies against IgA1 protease are stimulated both by clinical disease and by asymptomatic carriage of serogroup A Neisseria meningitidis. J Infect Dis. 166:1992;1316-1321.
15. Thiesen B, Greenwood B, Brieske N, Achtman M Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein. Vaccine. 15:1997;209-219.
16. Rokbi B, Mazarin V, Maitre-Wilmotte G, Quentin-Millet M-J Identification of two major families of transferrin receptors among Neisseria meningitidis strains based on antigenic and genomic features. FEMS Microbiol Lett. 110:1993;51-58.
17. Rokbi B, Mignon M, Caugant D.A, Quentin-Millet M.J Heterogeneity of tbpB, the transferrin-binding protein B gene, among serogroup B Neisseria meningitidis strains of the ET-5 complex. Clin Diagn Lab Immunol. 4:1997;522-529.
18. Mazarin V, Rokbi B, Quentin-Millet M-J Genetic diversity of the transferrin-binding protein Tbp2 of Neisseria meningitidis. Gene. 158:1995;145-146.
19. Morelli G, Malorny B, Müller Ket al. Clonal descent and microevolution of Neisseria meningitidis during 30 years of epidemic spread. Mol Microbiol. 25:1997;1047-1064.
20. Morelli G, del Valle J, Lammel C.Jet al. Immunogenicity and evolutionary variability of epitopes within IgA1 protease from serogroup A Neisseria meningitidis. Mol Microbiol. 11:1994;175-187.
21. Hassan-King M.K.A, Wall R.A, Greenwood B.M Meningococcal carriage, meningococcal disease and vaccination. J Infection. 16:1988;55-59.
22. Crowe B.A, Wall R.A, Kusecek Bet al. Clonal and variable properties of Neisseria meningitidis isolated from cases and carriers during and after an epidemic in the Gambia. West Africa J Infect Dis. 159:1989;686-700.
23. Achtman M, Wall R.A, Bopp Met al. Variation in Class 5 protein expression by serogroup A meningococci during a meningitis epidemic. J Infect Dis. 164:1991;375-382.
24. Wang J-F, Caugant D.A, Morelli G, Koumaré B, Achtman M Antigenic and epidemiological properties of the ET-37 complex of Neisseria meningitidis. J Infect Dis. 167:1993;1320-1329.
25. Koumaré B, Achtman M, Bougoudogo F, Cisse M, Wang J.F Molecular epidemiology of meningitis due to Neisseria meningitidis in Mali: Isolation of a new variant (P1.y) of the class 1 protein. Bull World Health Organ. 74:1996;375-379.
26. Delvig A.A, Koumaré B, Glaser R.W, Wang J, Jahn S, Achtman M Comparison of three human-murine heteromyeloma cell lines for formation of human hybridomas after electrofusion with human peripheral blood lymphocytes from meningococcal cases and carriers. Hum Antibod Hybridomas. 6:1995;42-46.
27. Legrain M, Mazarin V, Irwin S.Wet al. Cloning and characterization of Neisseria meningitidis genes encoding the transferrin-binding proteins Tbp1 and Tbp2. Gene. 130:1993;73-80.
28. Gheesling L.L, Carlone G.M, Pais L.Bet al. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol. 32:1994;1475-1482.
29. Danve B, Lissolo L, Mignon Met al. Transferrin-binding proteins isolated from Neisseria meningitidis elicit protective and bactericidal antibodies in laboratory animals. Vaccine. 11:1993;1214-1220.
30. Dempsey J.A.F, Wallace A.B, Cannon J.G The physical map of the chromosome of a serogroup A strain of Neisseria meningitidis shows complex rearrangements relative to the chromosomes of two mapped strains of the closely related species N. gonorrhoeae. J Bacteriol. 177:1995;6390-6400.
31. Strutzberg K, von Olleschik L, Franz B, Pyne C, Schmidt M.A, Gerlach G-F Mapping of functional regions in the transferrin-binding protein (TfbA) of Actinobacillus pleuropneumoniae. Infect Immun. 63:1995;3846-3850.
32. Achtman M, Kusecek B, Morelli Get al. A comparison of the variable antigens expressed by clone IV-1 and subgroup III of Neisseria meningitidis serogroup A. J Infect Dis. 165:1992;53-68.
33. Griffiss J.M Epidemic meningococcal disease: Synthesis of a hypothetical immunoepidemiologic model. Rev Infect Dis. 4:1982;159-172.
34. Griffiss J.M Serum IgA: Modulation of complement activation and induction of susceptibility to bacterial dissemination. Infection. 10:1982;246-251.
35. Griffiss J.M, Goroff D.K IgA blocks IgM and IgG-initiated immune lysis by separate molecular mechanisms. J Immunol. 130:1983;2882-2885.
36. Gorringe A.R, Borrow R, Fox A.J, Robinson A Human antibody response to meningocaccal transferrin binding proteins: evidence for vaccine potential. Vaccine. 13:1995;1207-1212.
37. Guttormsen H-K, Wetzler L.M, Solberg C.O Humoral immune response to class 1 outer membrane protein during the course of meningococcal disease. Infect Immun. 62:1994;1437-1443.
38. Guttormsen H-K, Wetzler L.M, Næss A Humoral immune response to the class 3 outer membrane protein during the course of meningococcal disease. Infect Immun. 61:1993;4734-4742.